Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates Born to HIV-1-Infected Women
Open Access
- 1 March 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (5) , 801-807
- https://doi.org/10.1086/319215
Abstract
To determine the safety of 2 candidate vaccines against human immunodeficiency virus type 1 (HIV-1), a randomized, placebo-controlled, multicenter trKeywords
This publication has 13 references indexed in Scilit:
- Lymphoproliferative Responses to Recombinant HIV‐1 Envelope Antigens in Neonates and Infants Receiving gp120 VaccinesThe Journal of Infectious Diseases, 2000
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-Infected Infants and ChildrenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency VirusNew England Journal of Medicine, 1998
- Safety of the maternal–infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 StudyAIDS, 1998
- Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South AfricaAIDS, 1998
- Update: Perinatally Acquired HIV/AIDS—United States, 1997Published by American Medical Association (AMA) ,1997
- Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation GroupAIDS Research and Human Retroviruses, 1997
- Infant survival, HIV infection, and feeding alternatives in less-developed countries.American Journal of Public Health, 1997
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994